A phase II study of a 3-day schedule with topotecan and cisplatin every three weeks in patients with previously in treated small cell lung cancer and extensive disease: Final results.
Publikation: Bidrag til tidsskrift › Konferenceartikel › Forskning › fagfællebedømt
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Journal of Clinical Oncology |
| Vol/bind | 22 |
| Udgave nummer | 14 |
| Sider (fra-til) | 667S-667S |
| Antal sider | 1 |
| ISSN | 0732-183X |
| Status | Udgivet - 15 jul. 2004 |
| Begivenhed | 40th Annual Meeting of the American-Society-of-Clinical-Oncology - New Orleans, Laos Varighed: 5 jun. 2004 → 8 jun. 2004 |
Konference
| Konference | 40th Annual Meeting of the American-Society-of-Clinical-Oncology |
|---|---|
| Land | Laos |
| By | New Orleans |
| Periode | 05/06/2004 → 08/06/2004 |
ID: 335375655